Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine

Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine

Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular endothelium growth factor (VEGF) plays a leading role in angiogenesis progression.<b> </b>Antiangiogenic medication has gained substantial recognition and is commonly administered in many forms of hu...

Full description

Bibliographic Details
Main Authors: Hashem O. Alsaab, Alanoud S. Al-Hibs, Rami Alzhrani, Khawlah K. Alrabighi, Aljawharah Alqathama, Akram Alwithenani, Atiah H. Almalki, Yusuf S. Althobaiti
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
angiogenesis
antiangiogenics
nanomedicine
theranostic
VEGF receptors
angiogenesis biomarkers
Online Access:https://www.mdpi.com/1422-0067/22/4/1631

Internet

https://www.mdpi.com/1422-0067/22/4/1631

Similar Items